SEC Form 4Coverage since Jun 1, 2026
$MIRM insider trading
Over the last 12 months, Mirum Pharmaceuticals insiders reported no purchases and 13 sales totaling $7.6M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $7.6M 13 events
- Events · 12m
- 13 Form 4 filings, grouped
- Insiders · 12m
- 4 distinct reporters
- 10b5-1 share
- 100% pre-arranged plans
Side
Price · $MIRM · 12Mvia TradingView
Top insiders · 12m
Peetz ChristopherCHIEF EXECUTIVE OFFICER7× · $5.3M
Howe JolandaSVP, GLOBAL CONTROLLER3× · $785K
BJERKHOLT ERICCHIEF FINANCIAL OFFICER2× · $1.1M
Ramasastry Saira—1× · $398K
All insider trades
13 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | Howe JolandaSVP, GLOBAL CONTROLLER · O | ▼ Sale | 1,840 | $105.29 | $194K | -59.1% | plan |
| Jul 6, 2026 | Peetz ChristopherCHIEF EXECUTIVE OFFICER · O·D | ▼ Sale | 20,000 | $122.27 | $2.4M | -9.3% | plan · 4 tranches |
| Jul 6, 2026 | BJERKHOLT ERICCHIEF FINANCIAL OFFICER · O | ▼ Sale | 5,000 | $122.25 | $611K | -10.6% | plan · 4 tranches |
| Jul 1, 2026 | Howe JolandaSVP, GLOBAL CONTROLLER · O | ▼ Sale | 2,721 | $120 | $327K | -46.6% | plan |
| Jun 17, 2026 | Howe JolandaSVP, GLOBAL CONTROLLER · O | ▼ Sale | 2,594 | $101.95 | $264K | -30.8% | plan |
| Jun 8, 2026 | BJERKHOLT ERICCHIEF FINANCIAL OFFICER · O | ▼ Sale | 5,000 | $93.82 | $469K | -10% | plan · 3 tranches |
| Jun 1, 2026 | Peetz ChristopherCHIEF EXECUTIVE OFFICER · O·D | ▼ Sale | 883 | $99.66 | $88K | -0.5% | plan |
| Jun 1, 2026 | Peetz ChristopherCHIEF EXECUTIVE OFFICER · O·D | ▼ Sale | 1,021 | $98.2 | $100K | -0.5% | plan |
| Jun 1, 2026 | Peetz ChristopherCHIEF EXECUTIVE OFFICER · O·D | ▼ Sale | 1,973 | $97.56 | $192K | -1% | plan |
| Jun 1, 2026 | Peetz ChristopherCHIEF EXECUTIVE OFFICER · O·D | ▼ Sale | 6,926 | $96.15 | $666K | -3.4% | plan |
| Jun 1, 2026 | Peetz ChristopherCHIEF EXECUTIVE OFFICER · O·D | ▼ Sale | 16,595 | $95.34 | $1.6M | -7.5% | plan |
| Jun 1, 2026 | Peetz ChristopherCHIEF EXECUTIVE OFFICER · O·D | ▼ Sale | 2,602 | $94.64 | $246K | -1.2% | plan |
| Jun 1, 2026 | Ramasastry SairaD | ▼ Sale | 3,977 | $100 | $398K | -100% | plan |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $MIRM feed.